{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:16:54Z","timestamp":1773058614999,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10067-019-04563-9","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T07:04:27Z","timestamp":1556262267000},"page":"2493-2500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-0754","authenticated-orcid":false,"given":"Marco","family":"Krasselt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Baerwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe G.","family":"Liebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"issue":"11","key":"4563_CR1","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1002\/art.38804","volume":"66","author":"C Rondaan","year":"2014","unstructured":"Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, van Assen S, Bijl M, Westra J (2014) Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis Rheumatol 66(11):3122\u20133128. \n                    https:\/\/doi.org\/10.1002\/art.38804","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"4563_CR2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/acr.21928","volume":"65","author":"BM Veetil","year":"2013","unstructured":"Veetil BM, Myasoedova E, Matteson EL, Gabriel SE, Green AB, Crowson CS (2013) Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 65(6):854\u2013861. \n                    https:\/\/doi.org\/10.1002\/acr.21928","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"13","key":"4563_CR3","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1056\/NEJMct066061","volume":"356","author":"DW Kimberlin","year":"2007","unstructured":"Kimberlin DW, Whitley RJ (2007) Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 356(13):1338\u20131343. \n                    https:\/\/doi.org\/10.1056\/NEJMct066061","journal-title":"N Engl J Med"},{"issue":"22","key":"4563_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan ISF, Wang WWB, Annunziato PW, Silber JL (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352(22):2271\u20132284. \n                    https:\/\/doi.org\/10.1056\/NEJMoa051016","journal-title":"N Engl J Med"},{"issue":"5","key":"4563_CR5","first-page":"791","volume":"30","author":"CM Barbosa","year":"2012","unstructured":"Barbosa CM, Terreri MT, Rosario PO, de Moraes-Pinto MI, Silva CA, Hilario MO (2012) Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol 30(5):791\u2013798","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4563_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2012.7304","volume":"308","author":"J Zhang","year":"2012","unstructured":"Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, Saag KG, Baddley JW, Curtis JR (2012) Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 308(1):43\u201349. \n                    https:\/\/doi.org\/10.1001\/jama.2012.7304","journal-title":"JAMA"},{"issue":"5","key":"4563_CR7","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/ar3497","volume":"13","author":"J Zhang","year":"2011","unstructured":"Zhang J, Delzell E, Xie F, Baddley JW, Spettell C, McMahan RM et al (2011) The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res Ther 13(5):R174. \n                    https:\/\/doi.org\/10.1186\/ar3497","journal-title":"Arthritis Res Ther"},{"issue":"52","key":"4563_CR8","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","volume":"35","author":"ED Willis","year":"2017","unstructured":"Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, Halsey NA, Gershon AA (2017) Herpes zoster vaccine live: a 10year review of post-marketing safety experience. Vaccine 35(52):7231\u20137239. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.013","journal-title":"Vaccine"},{"issue":"11","key":"4563_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J et al (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375(11):1019\u20131032. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1603800","journal-title":"N Engl J Med"},{"issue":"22","key":"4563_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barber\u00e0 J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372(22):2087\u20132096. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1501184","journal-title":"N Engl J Med"},{"key":"4563_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2018.1514228","volume":"15","author":"CC Mok","year":"2018","unstructured":"Mok CC (2018) Herpes zoster vaccination in systemic lupus erythematosus: the current status. Hum Vaccin Immunother 15:1\u20134. \n                    https:\/\/doi.org\/10.1080\/21645515.2018.1514228","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"4563_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00296-016-3608-y","volume":"37","author":"M Krasselt","year":"2017","unstructured":"Krasselt M, Ivanov JP, Baerwald C, Seifert O (2017) Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic. Rheumatol Int 37(2):229\u2013237. \n                    https:\/\/doi.org\/10.1007\/s00296-016-3608-y","journal-title":"Rheumatol Int"},{"issue":"8","key":"4563_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00393-017-0410-5","volume":"77","author":"M Krasselt","year":"2018","unstructured":"Krasselt M, Baerwald C, Seifert O (2018) Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic. Z Rheumatol 77(8):727\u2013734. \n                    https:\/\/doi.org\/10.1007\/s00393-017-0410-5","journal-title":"Z Rheumatol"},{"issue":"3","key":"4563_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2010.137216","volume":"70","author":"S Assen van","year":"2011","unstructured":"van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JPA, Jayne DRW, Kallenberg CGM, Muller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70(3):414\u2013422. \n                    https:\/\/doi.org\/10.1136\/ard.2010.137216","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4563_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625\u2013639. \n                    https:\/\/doi.org\/10.1002\/acr.21641","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"4563_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588. \n                    https:\/\/doi.org\/10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4563_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","volume":"18","author":"E Elm von","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18(6):800\u2013804. \n                    https:\/\/doi.org\/10.1097\/EDE.0b013e3181577654","journal-title":"Epidemiology"},{"issue":"5","key":"4563_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1586\/1744666X.2014.904746","volume":"10","author":"M Krasselt","year":"2014","unstructured":"Krasselt M, Baerwald C (2014) The current relevance and use of prednisone in rheumatoid arthritis. Expert Rev Clin Immunol 10(5):557\u2013571. \n                    https:\/\/doi.org\/10.1586\/1744666X.2014.904746","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"4563_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/528696","volume":"197","author":"MJ Levin","year":"2008","unstructured":"Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan ISF, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A, Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators (2008) Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 197(6):825\u2013835. \n                    https:\/\/doi.org\/10.1086\/528696","journal-title":"J Infect Dis"},{"issue":"9","key":"4563_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/379048","volume":"188","author":"MJ Levin","year":"2003","unstructured":"Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan ISF, Li DJJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJR, Caulfield MJ (2003) Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 188(9):1336\u20131344. \n                    https:\/\/doi.org\/10.1086\/379048","journal-title":"J Infect Dis"},{"issue":"3","key":"4563_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0002-9343(80)90003-0","volume":"69","author":"RM Blaese","year":"1980","unstructured":"Blaese RM, Grayson J, Steinberg AD (1980) Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med 69(3):345\u2013350. \n                    https:\/\/doi.org\/10.1016\/0002-9343(80)90003-0","journal-title":"Am J Med"},{"key":"4563_CR22","doi-asserted-by":"publisher","unstructured":"Krasselt M, Baerwald C (2017) Sex, symptom severity, and quality of life in rheumatology. Clin Rev Allergy Immunol. \n                    https:\/\/doi.org\/10.1007\/s12016-017-8631-6","DOI":"10.1007\/s12016-017-8631-6"},{"issue":"8","key":"4563_CR23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/art.23112","volume":"57","author":"AL Smitten","year":"2007","unstructured":"Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA (2007) The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 57(8):1431\u20131438. \n                    https:\/\/doi.org\/10.1002\/art.23112","journal-title":"Arthritis Rheum"},{"issue":"12","key":"4563_CR24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.22628","volume":"67","author":"DA Pappas","year":"2015","unstructured":"Pappas DA, Hooper MM, Kremer JM, Reed G, Shan Y, Wenkert D, Greenberg JD, Curtis JR (2015) Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease-modifying antirheumatic drugs. Arthritis Care Res (Hoboken) 67(12):1671\u20131678. \n                    https:\/\/doi.org\/10.1002\/acr.22628","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"4563_CR25","doi-asserted-by":"publisher","first-page":"e014032","DOI":"10.1136\/bmjopen-2016-014032","volume":"7","author":"TL Liao","year":"2017","unstructured":"Liao TL, Chen YM, Liu HJ, Chen DY (2017) Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open 7(1):e014032. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2016-014032","journal-title":"BMJ Open"},{"issue":"10","key":"4563_CR26","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1002\/art.40189","volume":"69","author":"KL Winthrop","year":"2017","unstructured":"Winthrop KL, Curtis JR, Lindsey S, Tanaka Y, Yamaoka K, Valdez H, Hirose T, Nduaka CI, Wang L, Mendelsohn AM, Fan H, Chen C, Bananis E (2017) Herpes zoster and Tofacitinib: clinical outcomes and the risk of concomitant therapy. Arthritis Rheumatol 69(10):1960\u20131968. \n                    https:\/\/doi.org\/10.1002\/art.40189","journal-title":"Arthritis Rheumatol"},{"key":"4563_CR27","doi-asserted-by":"publisher","unstructured":"Curtis JR, Xie F, Yang S, Bernatsky S, Chen L, Yun H, Winthrop K (2018) Herpes zoster in tofacitinib: risk is further increased with glucocorticoids but not methotrexate. Arthritis Care Res (Hoboken). \n                    https:\/\/doi.org\/10.1002\/acr.23769","DOI":"10.1002\/acr.23769"},{"issue":"10","key":"4563_CR28","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/art.40187","volume":"69","author":"KL Winthrop","year":"2017","unstructured":"Winthrop KL, Wouters AG, Choy EH, Soma K, Hodge JA, Nduaka CI, Biswas P, Needle E, Passador S, Mojcik CF, Rigby WF (2017) The safety and immunogenicity of live zoster vaccination in patients with rheumatoid arthritis before starting tofacitinib: a randomized phase II trial. Arthritis Rheumatol 69(10):1969\u20131977. \n                    https:\/\/doi.org\/10.1002\/art.40187","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"4563_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrrheum.2009.180","volume":"5","author":"CM Weyand","year":"2009","unstructured":"Weyand CM, Fujii H, Shao L, Goronzy JJ (2009) Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 5(10):583\u2013588. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2009.180","journal-title":"Nat Rev Rheumatol"},{"issue":"Supplement_5","key":"4563_CR30","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1513\/AnnalsATS.201602-095AW","volume":"13","author":"CM Weyand","year":"2016","unstructured":"Weyand CM, Goronzy JJ (2016) Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc 13(Supplement_5):S422\u2013S428. \n                    https:\/\/doi.org\/10.1513\/AnnalsATS.201602-095AW","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"4563_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.rdc.2010.03.001","volume":"36","author":"JJ Goronzy","year":"2010","unstructured":"Goronzy JJ, Shao L, Weyand CM (2010) Immune aging and rheumatoid arthritis. Rheum Dis Clin N Am 36(2):297\u2013310. \n                    https:\/\/doi.org\/10.1016\/j.rdc.2010.03.001","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"4563_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0037-1622017","volume":"23","author":"ML Krasselt","year":"2014","unstructured":"Krasselt ML, Wagner U (2014) Ageing and immunity. Osteology 23(3):195\u2013201","journal-title":"Osteology"},{"issue":"5","key":"4563_CR33","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1186\/ar4321","volume":"15","author":"M Krasselt","year":"2013","unstructured":"Krasselt M, Baerwald C, Wagner U, Rossol M (2013) CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence. Arthritis Res Ther 15(5):R139. \n                    https:\/\/doi.org\/10.1186\/ar4321","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4563_CR34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/art.27194","volume":"62","author":"CS Crowson","year":"2010","unstructured":"Crowson CS, Liang KP, Therneau TM, Kremers HM, Gabriel SE (2010) Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum 62(2):378\u2013382. \n                    https:\/\/doi.org\/10.1002\/art.27194","journal-title":"Arthritis Rheum"},{"issue":"2\u20133","key":"4563_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0047-6374(97)00161-9","volume":"102","author":"CM Weyand","year":"1998","unstructured":"Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ (1998) Functional properties of CD4+ CD28- T cells in the aging immune system. Mech Ageing Dev 102(2\u20133):131\u2013147","journal-title":"Mech Ageing Dev"},{"key":"4563_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12948-017-0077-0","volume":"15","author":"MT Ventura","year":"2017","unstructured":"Ventura MT, Casciaro M, Gangemi S, Buquicchio R (2017) Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clin Mol Allergy 15:21. \n                    https:\/\/doi.org\/10.1186\/s12948-017-0077-0","journal-title":"Clin Mol Allergy"},{"issue":"5","key":"4563_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10522-011-9353-4","volume":"12","author":"S Buffa","year":"2011","unstructured":"Buffa S, Bulati M, Pellicano M, Dunn-Walters DK, Wu YC, Candore G et al (2011) B cell immunosenescence: different features of naive and memory B cells in elderly. Biogerontology 12(5):473\u2013483. \n                    https:\/\/doi.org\/10.1007\/s10522-011-9353-4","journal-title":"Biogerontology"},{"issue":"2","key":"4563_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1874609808666150727110744","volume":"8","author":"P Chalan","year":"2015","unstructured":"Chalan P, van den Berg A, Kroesen BJ, Brouwer L, Boots A (2015) Rheumatoid arthritis, immunosenescence and the hallmarks of aging. Curr Aging Sci 8(2):131\u2013146","journal-title":"Curr Aging Sci"},{"issue":"3","key":"4563_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000358437","volume":"22","author":"LE Petersen","year":"2015","unstructured":"Petersen LE, Grassi-Oliveira R, Siara T, dos Santos SG, Ilha M, de Nardi T et al (2015) Premature immunosenescence is associated with memory dysfunction in rheumatoid arthritis. Neuroimmunomodulation 22(3):130\u2013137. \n                    https:\/\/doi.org\/10.1159\/000358437","journal-title":"Neuroimmunomodulation"},{"issue":"7","key":"4563_CR40","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/art.38625","volume":"66","author":"KS Geest van der","year":"2014","unstructured":"van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG et al (2014) Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica. Arthritis Rheumatol 66(7):1927\u20131938. \n                    https:\/\/doi.org\/10.1002\/art.38625","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4563_CR41","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/eji.201444878","volume":"45","author":"T Pritz","year":"2015","unstructured":"Pritz T, Lair J, Ban M, Keller M, Weinberger B, Krismer M, Grubeck-Loebenstein B (2015) Plasma cell numbers decrease in bone marrow of old patients. Eur J Immunol 45(3):738\u2013746. \n                    https:\/\/doi.org\/10.1002\/eji.201444878","journal-title":"Eur J Immunol"},{"issue":"4","key":"4563_CR42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1084\/jem.157.4.1300","volume":"157","author":"D Zharhary","year":"1983","unstructured":"Zharhary D, Klinman NR (1983) Antigen responsiveness of the mature and generative B cell populations of aged mice. J Exp Med 157(4):1300\u20131308","journal-title":"J Exp Med"},{"issue":"4","key":"4563_CR43","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1084\/jem.144.4.1037","volume":"144","author":"EA Goidl","year":"1976","unstructured":"Goidl EA, Innes JB, Weksler ME (1976) Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med 144(4):1037\u20131048","journal-title":"J Exp Med"},{"issue":"5","key":"4563_CR44","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11357-012-9488-5","volume":"35","author":"S Buffa","year":"2013","unstructured":"Buffa S, Pellicano M, Bulati M, Martorana A, Goldeck D, Caruso C et al (2013) A novel B cell population revealed by a CD38\/CD24 gating strategy: CD38(\u2212)CD24 (\u2212) B cells in centenarian offspring and elderly people. Age (Dordr) 35(5):2009\u20132024. \n                    https:\/\/doi.org\/10.1007\/s11357-012-9488-5","journal-title":"Age (Dordr)"},{"issue":"1","key":"4563_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-017-1423-9","volume":"19","author":"N Sherina","year":"2017","unstructured":"Sherina N, Hreggvidsdottir HS, Bengtsson C, Hansson M, Israelsson L, Alfredsson L, Lundberg K (2017) Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology. Arthritis Res Ther 19(1):219. \n                    https:\/\/doi.org\/10.1186\/s13075-017-1423-9","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4563_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1086\/338043","volume":"34","author":"O Elkayam","year":"2002","unstructured":"Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, Rubins JB (2002) Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 34(2):147\u2013153. \n                    https:\/\/doi.org\/10.1086\/338043","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4563_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/art.25034","volume":"62","author":"CO Bingham 3rd","year":"2010","unstructured":"Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C et al (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64\u201374. \n                    https:\/\/doi.org\/10.1002\/art.25034","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4563_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","volume":"45","author":"MC Kapetanovic","year":"2006","unstructured":"Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45(1):106\u2013111. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kei193","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4563_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2005.036434","volume":"65","author":"I Fomin","year":"2006","unstructured":"Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D et al (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65(2):191\u2013194. \n                    https:\/\/doi.org\/10.1136\/ard.2005.036434","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4563_CR50","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/ard.2007.077461","volume":"67","author":"S Oren","year":"2008","unstructured":"Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O (2008) Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 67(7):937\u2013941. \n                    https:\/\/doi.org\/10.1136\/ard.2007.077461","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4563_CR51","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3899\/jrheum.170936","volume":"45","author":"JH Koh","year":"2018","unstructured":"Koh JH, Lee J, Kim SH, Kwok SK, Ju JH, Park SH (2018) Safety, and humoral and cell-mediated immune responses to herpes zoster vaccine in patients with rheumatoid arthritis. J Rheumatol 45(4):465\u2013469. \n                    https:\/\/doi.org\/10.3899\/jrheum.170936","journal-title":"J Rheumatol"},{"issue":"10","key":"4563_CR52","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","volume":"81","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Gilden D (2013) The global epidemiology of herpes zoster. Neurology 81(10):928\u2013930. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a3516e","journal-title":"Neurology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04563-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04563-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T23:18:44Z","timestamp":1587770324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04563-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4563"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04563-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"19 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Krasselt declares no conflict of interest. Professor Baerwald received lecture fees from Merck, MSD, Mundipharma and Pfizer. Professor Liebert and Dr. Seifert declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"All procedures performed in this survey were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Data obtained in this study did not interfere with the course of treatment for patients included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}